Ginkgo Bioworks Holdings
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +28.9% | +109.7% | +46.3% | +68.2% | -11.9% | -6.4% | |
| – | -38.3% | +337,299.2% | +20.2% | -88.1% | -51.1% | -27.4% | |
| – | -93.6% | +46,800.6% | +15.6% | – | – | – | |
| – | -350.7% | – | – | – | -400.5% | – | |
| – | +160.2% | -2.2% | -7.5% | -21.9% | +53.3% | -87.7% | |
| – | -10.0% | +9.1% | -8.0% | +19.7% | -22.9% | +286.1% | |
| – | – | – | -99.9% | – | – | – | |
| – | – | -127.5% | +0.0% | -99.9% | – | +23,077.4% | |
| – | -100.4% | +50.1% | – | -101.3% | -30.7% | -60.5% | |
| – | -78.0% | +1,598.6% | -93.8% | -103.4% | -45.9% | – | |
| – | -138.7% | – | -118.5% | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.